PUBLISHER: Grand View Research | PRODUCT CODE: 1869731
PUBLISHER: Grand View Research | PRODUCT CODE: 1869731
The global ophthalmic diagnostic devices market size was valued at USD 15.34 billion in 2024 and is projected to reach USD 20.69 billion by 2033, growing at a CAGR of 3.35% from 2025 to 2033. This growth is attributed to the growing geriatric population, prevalence of chronic diseases, and increasing awareness and screening programs.
Another primary factor for market growth is technological advancement, which has resulted in many diagnostic solutions that are more accurate, less invasive, and automated. Technology that has been created and refined, such as optical coherence tomography (OCT), artificial intelligence (AI) assisted retinal imaging, adaptive optics, visual evoked potential (VEP), and corneal topography, has facilitated the early detection of eye disease and monitoring of its progression. Devices that are portable and smart, such as handheld fundus cameras and dark adaptometers, offer more convenience for patients and accessibility. For instance, an article published by the PMC Ophthalmology explains that these technologies, such as allowing for high-resolution imaging of the eye and real-time analysis for clinical diagnostics, are being used by hospitals such as the Thind Eye Hospital that have shown examples of the practical application of integrating AI and precision eye tracking in devices such as the AdaptDx Pro system and NOVA Vision Testing System.
The aging population and the growing incidence of chronic diseases are other factors affecting market growth that influence ophthalmic diagnosis. Aging affects vision by gradually impairing the structure and function of the eye, leading to conditions such as cataracts and age-related macular degeneration (AMD). These issues reduce transparency in the lens and damage the macula area of the retina, ultimately leading to distorted and blurry vision. Regular eye examinations employing advanced ophthalmic diagnostic equipment, such as optical coherence tomography (OCT) and fundus imaging, can facilitate the timely detection and monitoring of age-related disorders.
Additional risk factors like oxidative stress, inflammation, and genetic predisposition can result in more rapid vision loss among older adults. For instance, in 2024, a review published in Progress in Retinal and Eye Research highlighted that age-related changes in the lens and retina, such as cataract formation and macular degeneration, increase the need for precise ophthalmic diagnostic imaging. Advanced devices like Optical Coherence Tomography (OCT) and fundus cameras enable early detection and monitoring, helping healthcare providers manage ocular health more effectively in older adults.
Adding to this, chronic health conditions like diabetes and hypertension affect age-related vision health tremendously. In diabetes, sustained high blood sugar can result in diabetic retinopathy, while uncontrolled blood pressure may lead to hypertensive retinopathy. Both conditions damage the blood vessels found in the retina and can cause diseases such as macular edema, glaucoma, or even permanent vision loss if not managed properly.
Global Ophthalmic Diagnostic Devices Market Report Segmentation
This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ophthalmic diagnostic devices market report on the basis of product, function, procurement/ownership, application, end use, and region: